Itch: Association with chronic venous disease, pain, and quality of life

Journal of Wound, Ostomy and Continence Nursing

Volumn 38, Issue 1, 2011, Pages 46-54

  Paul, Julia C ^a   Pieper, Barbara ^a   Templin, Thomas N ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ANALYSIS OF VARIANCE; ARTICLE; ATTITUDE TO HEALTH; CHRONIC DISEASE; CLASSIFICATION; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; NURSE; NURSING; NURSING METHODOLOGY RESEARCH; PAIN; PRURITUS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SKIN CARE; STATISTICS; SUBSTANCE ABUSE; UNITED STATES; VEIN INSUFFICIENCY;

ADULT; AFRICAN AMERICANS; AGED; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MIDWESTERN UNITED STATES; NURSE CLINICIANS; NURSING METHODOLOGY RESEARCH; PAIN; PRURITUS; QUALITY OF LIFE; SKIN CARE; SUBSTANCE ABUSE, INTRAVENOUS; VENOUS INSUFFICIENCY;

EID: 78951473214     PISSN: 10715754     EISSN: None     Source Type: Journal    
DOI: 10.1097/WON.0b013e318202c47a     Document Type: Article

References (45)

1. Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006:7:535-547.
2. Yosipovitch G, Stander S. Meeting report of the 3rd International Workshop for the Study of Itch. J Invest Dermatol. 2006:1928-1930.
3. Yosipovitch G, Greaves M. Definitions of itch. In: G Yosipovitch, MW Greaves, AB Fleischer, F McGlone, eds. Itch: Basic Mechanisms and Therapy. New York: Marcel Dekker, Inc.; 2004.
4. Burrows C, Miller R, Townsend D, et al.Best practice recommendations for the prevention and treatment of venous leg ulcers: Update 2006. Adv Skin Wound Care. 2007;20(11):611-623.
5. Stander S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol. 2003;139(11):1463-1470.
6. Waxler B, Dadabhoy ZP, Stojiljkovic L, Rabito SF. Primer of postoperative pruritus for anesthesiologists. Anesthesiol. 2005; 103:168-178.
7. Bernhard JD. (Ed.). Itch: Mechanisms and Management of Pruritus. New York: McGraw-Hill, Inc.; 1994.
8. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjork HE. Specific C receptors for itch in human skin. J Neurosci. 1997;17(20):8003-8008.
9. Heymann WR. Itch. J Am Acad Dermatol. 2006;54(4):705-706.
10. Paus R, Schmelz M, Biro T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest. 2006;116(5):1174-1185.
11. Twycross R, Greaves MW, Handwerker H, et al. Itch: Scratching more than the surface. Q J Med. 2003;96(1):7-26.
12. Baker R, Zeller R, Klein R, Thornton R, Shuber, Marshall R. Burn wound itch control using H1 and H2 antagonists. J Burn Care Rehabil. 2001;22(4):263-268.
13. Yosipovitch G, Hundley JL. Practical guidelines for relief of itch. Dermatol Nurs. 2004;16(4):325-238.
14. Bergan JJ, Schmid-Schonbein GW, Coleridge Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006;355:488-498.
15. Duque MI, Yosipovitch G, Chan YH, Smith R, Levy P. Itch, pain, and burning sensation are common symptoms in mild to moderate chronic venous insufficiency with an impact on quality of life. J Am Acad Dermatol. 2005;53(3):504-508.
16. Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248-1252.
17. Shai A, Halevy S. Direct ulceration in patients with venous insufficiency. Int J Dermatol. 2005;44:1006-1009.
18. Mendham J. Gabapentin for the treatment of itching produced by burns and wound healing in children: a pilot study. Burns. 2004;30(8):851-853.
19. Matheson J, Clayton J, Muller M. The reduction of itch during burn wound healing. J Burn Care Rehabil. 2001;22(1):76-81.
20. Hareendran A, Bradbury A, Budd J, Geroulakos G, Hobbs R, Kenkre J. Measuring the impact of venous leg ulcers on quality of life. J Wound Care. 2005;14(2):53-57.
21. Hareendran A, Doll H, Wild DJ, et al. The venous leg ulcer quality of life (VLU-Qol) questionnaire: development and psychometric validation. Wound Repair Regen. 2007;15:465-473.
22. Pieper B, Templin TN, Kirsner RS, Birk TJ. Impact of injection drug use on distribution and severity of chronic venous disorders. Wound Rep Reg. 2009;17(4):485-491.
23. Pieper B, Templin TN, Birk TJ, Kirsner RS. Reliability and clinical validity of a technique to assess lifetime illicit drug use. Ostomy Wound Manag. 2008;54(2):16-34.
24. Pieper B, Templin T. Chronic venous insufficiency in persons with a history of injection drug use. Res Nurs Health. 2001;24: 423-432.
25. Yosipovitch G, Zucker I, Boner G, Gafter U, Shapira Y, David M. A questionnaire for the assessment of pruritus: Validation in uremic patients. Acta Derm Venereol. 2001;81: 108-111.
26. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17:197-210.
27. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate, or severe? Grading pain severity by its interference with function. Pain. 1995;61:277-284.
28. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the brief pain inventory for chronic nonmalignant pain. J Pain. 2004;5:133-137.
29. Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B. 2002 How to Score Version 2 of the SF-12 Health Survey (With a Supplement Documenting Version 1). Lincoln, RI: QualityMetric Incorporated; 2002.
30. Pogatzki-Zahn E. Marziniak M, Schneider G, Luger TA, Stander S. Chronic pruritus: targets, mechanisms and future therapies. Drug News Perspect. 2008;21(10):541-551.
31. Globe D, Bayliss MS, Harrison DJ. The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups. Health Qual Life Outcomes. 2009;7:62.
32. Blome C, Augustin M, Siepmann D, Phan NQ, Rustenbach SJ, Stander S. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol. 2009;161:1143-1148.
33. Verhoeven EWM, Kraaimaat FW, van der Kerkhof PCM, et al. Prevalence of physical symptoms of itch, pain, and fatigue in patients with skin disease in general practice. Br J Dermatol, 2007;156:1346-1349.
34. Maida V, Ennis M, Kuzienisky C, Trozzolo L. Symptoms associated with malignant wounds: a prospective case study. J Pain Symptom Manag. 2009;37(2):206-211.
35. Dawn A, Papoiu ADP, Chan YH, Rapp SR, Rassette N, Yosipovitch G. Itch characteristics in atopic dermatitis: results of a webbased questionnaire. Br J Dermatol, 2009;160:642-644.
36. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circ. 2005;111:2398-2409.
37. Smith PC. The causes of skin damage and leg ulceration in chronic venous disease. Int J Low Extrem Wounds. 2006;5:160-167.
38. Brem H, Kirsner RS, Falanga V. Protocol for the successful treatment of venous ulcers. Am J Surg. 2004;188:1S-8S.
39. McMahon SB, Koltzenburg M. Itching for an explanation. Trends Neurosci. 1992;15:497-501.
40. Darsow U, Drzezga A, Ring J. Central nervous system imaging of itch with PET. In: Yosipovitch G, Greaves MW, Fleischer AB, McGlone F, Jr, eds. Itch: Basic Mechanisms and Therapy. New York: Marcel Dekker, Inc.; 2004:63-70.
41. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet. 2003; 361:690-694.
42. Carsten E, Kuraishi Y. Animal models of itch: scratching away at the problem. In: Yosipovitch G, Greaves MW, Fleischer AB, McGlone F, Jr eds. Itch: Basic Mechanisms and Therapy. New York: Marcel Dekker, Inc.; 2004:35-50.
43. Lawton S. Practical issues for emollient therapy in dry and itchy skin. Br J Nurs. 2009;18(16):978-984.
44. Yosipovitch G. Itch questionnaires as tools for itch evaluation. In: Yosipovitch G, Greaves MW, Fleischer AB, McGlone F, eds. Itch: Basic Mechanisms and Therapy. New York: Marcel Dekker, Inc.; 2004.
45. Darsow U, Scharein E, Simon D, Walter G, Bromm B, Ring J. New aspects of itch pathophysiology: Component analysis of atopic itch using the Eppendorf Itch Questionnaire. Int Arch Allergy Immunol. 2001;124:326-331.